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Objective. To investigate changes in serum pituitary-gonadal hormones and restoration of sexual and reproductive functions
after successful kidney transplantation. Patients and Methods. Serum pituitary-gonadal hormones before and after kidney
transplantation were measured in 78 patients with end-stage renal disease (ESRD) and in 30 healthy adults. Pre- and postoperative
semen specimens of 46 male recipients and 15 male controls were collected and compared. Additional 100 married kidney
transplant recipients without children were followed up for 3 years to observe their sexual function and fertility. Results.S e r u m
PRL, LH, and T or E2 levels gradually restored to the normal ranges in all kidney transplant recipients, and sperm density, motility,
viability, and morphology signiﬁcantly improved in the male recipients 4 months after successful kidney transplantation (P<. 05).
Thirty-three male recipients (55.93%) reobtained normal erectile function, and 49 kidney transplant recipients (61.25%) had
children within the 3-year follow-up period. Conclusion. Successful kidney transplantation could eﬀectively improve pituitary-
gonadal hormone disturbance and sexual and reproductive dysfunctions of ESRD patients.
1.Introduction
End-stage renal disease (ESRD) is usually associated with
pituitary-gonadal hormone disturbance, and most ESRD
patients are often perplexed by moderate or severe sexual
dysfunction[1].Althoughhemodialysisorperitonealdialysis
could prolong the survival time of ESRD patients signiﬁ-
cantly, it seems diﬃcult to recover the impaired pituitary-
gonadal axis function. Whether or not could sexual function
berestoredbysuccessfulkidneytransplantation?Akbarietal.
[2] found that serum testosterone (T) level remained low
andluteinizinghormone(LH)levelbeganincreasinginmost
malerecipientsduringhemodialysis,andthatbothTandLH
levels restored to the normal range after successful kidney
transplantation, implying that hemodialysis and kidney
transplantation might have diﬀerent eﬀects in improving
pituitary-gonadal axis dysfunction in ESRD patients.
Sexual dysfunction and infertility are not uncommon in
ESRD patients, and the occurrence of sexual dysfunction is
about 50% to 70% in both male and female patients during
dialysis [3]. According to the statistics, 30–40% male kidney
transplant recipients are younger than 50 years, and sexual
dysfunction and infertility are their major concerns before
transplantation. However, there are few studies concerning
serum pituitary-gonadal hormones and sexual dysfunction
and infertility during dialysis and after kidney transplanta-
tion in Asian populations. The present paper investigated
pre- and post-operative serum pituitary-gonadal hormones
and sexual function and fertility in a Chinese population
to see whether or not successful kidney transplantation2 International Journal of Nephrology
Table 1: Serum pituitary-gonadal hormone levels before and after transplantation in the 46 male ESRD patients and 15 male controls.
Item n PRL (ug/L) LH (IU/L) FSH (IU/L) T (nmol/L)
Control 15 8.42 ±0.94 14.00 ±4.01 17.00 ±3.12 23.50 ±4.61
Preop. 46 36.80 ±7.30
∗ 30.68 ±35.58
∗ 18.30 ±8.01 15.58 ±3.84
∗
1-2 months postop. 46 15.80 ±2.08 20.01 ±12.68 17.42 ±7.24 18.77 ±4.18
3-4 months postop. 46 9.41 ±1.12
† 13.84 ±6.72
† 16.84 ±6.72 22.94 ±4.86
†
∗P<. 01 versus control group; †P<. 01 versus preoperation.
could alleviate hormone disorders and improve sexual and
reproductive functions.
2. Patientsand Methods
2.1. Case Selection. Included in this study were 78 married
patients with ESRD (46 males and 32 females) who ranged
i na g ef r o m2 5t o4 5y e a r sw i t ham e a no f3 3y e a r s .T h e
course of disease ranged from 2 to 6 years (mean 3.6
years), and the preoperative course of dialysis ranged from
3 to 34 months (mean 7.5 months). ABO and Rh blood
types of the recipients and the donors were comparable,
and the proportion of dead cells in lymphocytotoxicity test
was <10%. Immunosuppressive therapy (Cyclosporine A
(CsA) + Azathioprine (AZA) + Prednisone) was initiated
from postoperative day 1. Additional 30 healthy adults (15
males and 15 females) with normal erectile function or
menstrualcycleswereselectedfromthefamilymembers(SCr
<2.0mg/dl) of the 78 patients as controls, who ranged in age
from26to45years(mean33years).Therewasnosigniﬁcant
diﬀerence in age, habits, and living environments between
the study and control groups.
Additional 100 married kidney transplant recipients (68
males and 32 females) without children who ranged from 26
to 45 years (mean 34 years) were followed up for 3 years.
Exclusion criteria were (1) recipients who were unmarried,
widowed, or divorced, (2) recipients who suﬀered from dia-
betes,hypertension,orotherdiseasesthatmightsigniﬁcantly
impair sexual or reproductive functions, and (3) recipients
who had children before kidney transplantation. These
recipients received the same immunosuppressive therapy.
All selected recipients in this study were from Shang-
hai Tenth People’s Hospital, 117th Hospital of PLA and
Changzheng Hospital. no organs were used from prisoners
and no subjects were prisoners in this study. Written
informed consents were obtained from all subjects involved.
This study was approved by the local ethics committee and
conducted in accordance with the Declaration of Helsinki
(1964).
2.2.Methods. Serumpituitary-gonadalhormonesweremea-
sured as follows: Venous blood samples of the 78ESRD
patients were collected during dialysis and at 1-2 and 3-4
monthspostoperatively,respectively.Bloodsamplesofthe32
female recipients were collected 4-5 days after the menstrual
period. Venous blood samples of the 30 healthy adults served
as controls. Serum prolactin (PRL), follicle stimulating hor-
mone (FSH), LH, and T or E2 were measured immediately
by electrochemiluminescence immunoassay (ElecsysSystem,
RocheDiagnositicsGmbH,Mannheim,Germany)according
to the manufacturer’s instructions. All blood samples were
measured in duplicate. Semen specimens of the 46 male
ESRD patients were collected before kidney transplantation
and4monthsaftertransplantationwhentheirrenalfunction
was nearly restored to the normal range, and semen speci-
mens of the 15 male healthy adults were used as the control.
All semen specimens were analyzed and compared between
the two groups.
The investigation items of the additional 100 married
kidney transplant recipients during the 3-year follow-up
period include recording and analyzing the day of ﬁrst
nocturnal erection and sexual activity after transplantation,
sexual desire, degree of erection, satisfaction with sexual
activities, frequency of sexual activities, and international
index of erectile function-5 (IIEF-5) score for the 68 male
patients and the day of ﬁrst menstruation and sexual activ-
ity after transplantation, satisfaction with sexual activities,
frequency of sexual activities, pregnancy, and reproductive
function for the 32 female patients.
2.3. Statistical Analyses. Statistical analyses were performed
with SPSS version 13.0 statistical software. Pre- and post-
operative serum pituitary-gonadal hormone levels, the vol-
ume of semen, and sperm viability, density, and morphology
were compared between the study and control groups, using
t test for independent samples. P<. 05 was considered
statistically signiﬁcant.
3. Results
3.1. Pre- and Postoperative Serum Pituitary-Gonadal Hor-
moneLevels. PreoperativeserumPRLandLHlevelsofthe46
male ESRD patients were signiﬁcantly higher, and serum T
level was signiﬁcantly lower than that of the 15 male controls
(both P<. 01). Serum PRL, LH, and T levels of the 46 male
ESRD patients gradually restored to the normal range after
transplantation, and 3-4 months after transplantation no
signiﬁcant diﬀerence in serum PRL, LH and T was observed
between the two groups (Table 1).
Preoperative serum PRL, LH, and FSH levels of the 32
female ESRD patients were signiﬁcantly higher, and serum
E2 level was signiﬁcantly lower than that of the 15 female
controls (both P<. 01). Serum PRL, LH, FSH, and E2
levels of the 32 female patients gradually restored to the
normal range after transplantation, and 3-4 months after
transplantation no signiﬁcant diﬀerence in serum PRL, LH,International Journal of Nephrology 3
Table 2: Serum pituitary-gonadal hormone levels before and after transplantation in the 32 female ESRD patients and 15 female controls.
Item n PRL (ug/L) LH (IU/L) FSH (IU/L) E2 (pmol/L)
Control 15 15.10 ±3.02 12.01 ±3.84 8.42 ±3.80 131.5 ±22.30
Preop. 32 24.60 ± 3.80
∗ 37.23 ±4.56
∗ 16.92 ±11.30
∗ 76.0 ±6.30
∗
1-2 months postop. 32 15.68 ±2.04 21.61 ±9.04 12.45 ±6.30 242.35 ±4.08
3-4 months postop. 32 16.30 ±1.42
† 13.04 ±2.62
† 10.10 ±7.60
† 124.50 ±27.23
†
∗P<. 01 versus control group; †P<. 01 versus preoperation.
Table 3: Comparison of pre- and post-operative semen analyses between the study and control groups.
Item n Volume (ml) Motility (%) Survival rate (%) Density (106/ml) Normal morphology (%)
control 15 3.3 ±0.46 4 .2 ±3.48 0 .5 ±2.47 2 .8 ±11.2 15%–27%
preoperative 46 1.7 ± 0.5
† 13.6 ±3.0
† 24.5 ±3.6
† 20.6 ±6.3
† 2%–12%†
4m o n t h sp o s t o p . 4 6 2 .9 ±0.6
∗ 60.9 ± 4.7
∗ 82.3 ±4.7
∗ 67.2 ±13.5
∗ 12%–25%∗
∗P<. 05 versus preoperative group; †P>. 05 versus control group.
FSH, and E2 levels was observed between the two groups
(Table 2).
3.2. Comparison of Pre- and Postoperative Semen Analyses.
Normal semen quality is deﬁned as sperm density >30 ×
106/ml, sperms that move forward >50%, and sperms in
normal morphology >14%. Of the 46 male ESRD patients,
12patients(26.09%)hadsevereoligospermia(spermdensity
was <5 × 106/ml), 29 patients (63.04%) had mild or
moderate oligospermia (sperm density was 5–30 × 106/ml),
and only 5 patients (10.87%) had normal sperm density
before transplantation, and the proportion of sperms in
normal morphology was only 2%–12%. Four months after
transplantation, sperm density, motility, and viability as
well as the proportion of sperms in normal morphology
were signiﬁcantly higher than those before transplantation
(P<. 05) (Table 3).
3.3. Sexual Function. Of the 100 married kidney transplant
recipients without children, 59 male and 21 female recipients
were followed up for more than 3 years, and the remaining
20 recipients lost followup by the end of this study.
3.3.1. Basic Information of the 80 Recipients
(1) Occupation. Researchers and civil servants (n = 21,
26.25%), workers (n = 35, 43.75%), farmers (n = 22,
27.5%), and freelancers (n = 2, 2.5%).
(2) Education. University or above (n = 22, 27.5%), senior
middle school (n = 31, 38.75%), junior middle school (n =
21, 26.25%), and primary school (n = 6, 7.5%).
(3) Marital Age. 1–18 years (mean 7.65 years).
(4)Fertility. 49(61.25%)hadchildren,andtheremaining31
(38.75%) had no children.
3.3.2. Sexual Function
(1) The day of ﬁrst postoperative nocturnal erection in
59male recipients wasaveragely45days (2–180 days)
after transplantation, and the ﬁrst postoperative
sexual activity occurred averagely 252 days (80–560
days) after transplantation. Pre- and post-operative
IIEF-5 scores of the 59 male recipients are listed
in Table 4. Four months after transplantation, 33
(55.93%) of the 59 male recipients who suﬀered
from diﬀerent degrees of erectile dysfunction before
transplantation reobtained normal erectile function
aftertransplantationandweresatisﬁedwiththeirsex-
ual activities. The mean frequency of postoperative
sexual activities was 4 times (1–10 times) monthly.
(2) The ﬁrst postoperative menstruation of the 21 female
recipients occurred averagely 38 days (5–90 days)
after transplantation, and the ﬁrst postoperative
sexual activity occurred averagely 324 days (110–
690 days) after transplantation. The mean frequency
of postoperative sexual activities was 1.6 times (1–4
times) monthly.
3.3.3. Fertility. Of the 80 recipients who were followed up
for 3 years, 49 (61.25%) had children and the remaining
31 (38.75%) had no children. Of the 21 female recipients
who were followed up for 3 years, 8 patients (38.10%)
had children, 4 patients (19.05%) experienced spontaneous
abortion during the ﬁrst trimenon of pregnancy, 5 patients
(23.81%) terminated their pregnancy because of edema-
hypertension-proteinuria syndrome or gradual worsening of
their renal function, and the remaining 4 patients (19.05%)
had never conceived.
3.3.4. Sexual Psychology. All recipients felt anxious about
or even afraid of sexual activities after transplantation, and
therefore the frequency of sexual activities was very low
or even naught in the ﬁrst year after transplantation. Of4 International Journal of Nephrology
Table 4: IIEF-5 score before and after kidney transplantation.
Item n IIEF-5 score
22–25 17–21 12–16 8–11 1–7
Preoperative
59
52 0 1 5 1 0 9
2m o n t h sp o s t o p . 1 6
∗ 18 11 8 6
4m o n t h sp o s t o p . 3 8
† 8† 6† 4† 3†
∗P<. 05, preoperation versus 2 months after operation; †P<. 05, preoperation versus 4 months after operation.
the 59 male recipients, 46 patients (77.97%) felt anxious
about sexual activities, 28 patients (47.46%) were afraid
of sexual activities, and 19 patients (32.20%) deemed that
sexual activities were harmful to the kidney grafts, even
though most of them tried their ﬁrst postoperative sexual
intercourse within the ﬁrst year after operation. Of the
21 female recipients, 17 patients (80.95%) deemed that
sexual activities were harmful to the grafts. This ﬁgure was
signiﬁcantlyhigherthanthatinthemalerecipients(P<. 05).
Our 3-year follow-up showed that 72 recipients (90.00%)
believed that sexual activities were unsafe within one year
after kidney transplantation.
3.4. Attitudes towards Their Recipient Spouses. Of the 80
recipients who were followed up for 3 years, 47 spouses
(58.75%) were willing to take care of the recipients lifetime,
25 spouses (31.25%) were willing for a take care of the
recipients for the time being, and the remaining 8 spouses
(10.00%) were unwilling to take care of the recipients at
all. Fifty-seven spouses (71.25%) believed that the recipients
could be cured. Twenty-ﬁve patients (31.25%) had marital
relationships as that before kidney transplantation; the
marital relationship became worse in 43 patients (53.75%)
after operation; 12 patients (15.00%) got divorced. Twenty-
six recipient spouses (32.50%) had extramarital aﬀairs, 23
spouses (28.75%) could tolerate no sexual activities with the
recipients, and 7 spouses (8.75%) felt disgusted about sexual
activities with the recipients and eventually left them.
4. Discussion
Serum T, FSH, LH, and PRL levels were abnormal in ESRD
patients even during hemodialysis or peritoneal dialysis [3–
5]. Previous studies [6] showed that serum T level remained
low and LH level was elevated in most ESRD patients
during hemodialysis, but these hormone proﬁles could be
restored after successful kidney transplantation, indicating
that dialysis and transplantation play diﬀerent roles in
restoring the pituitary-gonadal axis dysfunction in ESRD
patients. Pietrzak et al. [7] reported that 68.1% of their
female kidney transplant recipients had regular menstrual
cycles and ovulatory cycles similar to healthy women.
The pre- and post-operative hormone changes of the
78ESRD patients in our study indicated that the pituitary-
gonadal function was signiﬁcantly improved after kidney
transplantation. Serum T level in the male recipients and E2
level in the female recipients restored to the normal range
3-4 months after kidney transplantation. However, some
immunosuppressive regimens such as sirolimus seemed to
impair the improvement of gonadal function in kidney
transplant recipients [8]. Fritsche et al. [9]c o n d u c t e da
case-control study to compare serum T, FSH, LH, and PRL
levels in matched kidney transplant recipients treated with
or without sirolimus and found that serum T level was lower
FSH and LH were higher in sirolimus-treated recipients than
those in nonsirolimus-treated controls, but there was no
signiﬁcant diﬀerence in serum PRL level between the two
groups. Another study [10] reported that immunosuppres-
sive drugs such as TOR-I (target of rapamycin inhibitors)
might decrease serum T level and increase serum LH and
FSH levels. In addition, TOR-I might disrupt spermatoge-
nesis. Gonadal function could be improved by successful
kidney transplantation, but on the other hand, it could
also be impaired by immunosuppressive drugs. It remains
controversial whether kidney transplantation could improve
gonadal, sexual, and reproductive functions, especially in the
long run.
Sexual disorders are common in ESRD patients, and
about 50% of them had erectile dysfunction during dialysis
[11, 12], which may be caused by multiple factors including
lower serum T level, autonomic neuropathy, vascular dis-
eases, medications, deterioration of underlying diseases, and
psychological stress. It has been recognized that low serum T
level may be correlated with poor sexual desire and erectile
dysfunction. The results of our study showed that serum T
level, sexual activities, and IIEF-5 score improved markedly
after transplantation, which was consistent with the ﬁnding
of Lessan-Pezeshki and Ghazizadeh [13] and Shamsa et al.
[14].
There is no recognized appropriate time for recipients
to have the ﬁrst sexual activity after kidney transplantation,
although it mainly depends on the normal function of the
renal grafts and the overall situation of the recipients. It
was found in our study that the pituitary-gonadal function
nearly restored to the normal range in most recipients four
months after operation, suggesting that the ﬁrst postoper-
ative sexual activity could be attempted from four months
postoperatively. However, most recipients in our series did
not dare to have the ﬁrst postoperative sexual activity until
sixmonthslater;thefrequencyofsexualactivityinthefemale
recipients was less than that in the male recipients; the ﬁrst
day of postoperative sexual activity in the female recipients
was also two months later than that in the male recipients,
probably due to the misunderstanding that sexual activity
was harmful to the grafts, especially in female recipients. It is
therefore important to provide kidney recipients with timely
psychological consultation, support, and treatment.International Journal of Nephrology 5
Male ESRD patients are usually associated with sper-
matogenesis dysfunction, eventually leading to infertility.
Semen analysis showed that the volume of semen, sperm
count and motility were decreased in these patients. His-
tological examination of the testes further conﬁrmed that
spermatogenesis was inactive in such patients [15]. We
found that sperm density, motility, and viability as well
as the proportion of sperms in normal morphology were
signiﬁcantly higher 4 months after transplantation than
those before operation. However, kidney transplantation was
unable to recover spermatogenesis in patients who suﬀered
from uremia before or during adolescence, probably because
t h i sp e r i o di sc r u c i a lf o rs p e r m a t o g e n e s i s[ 16].
With the development of kidney transplantation tech-
nique and the application of new immunosuppressants,
pregnancy after kidney transplantation is no longer impos-
sible [17–19]. In this study, 49 recipients (61.25%) had
children, 8 female patients (38.10%) had children, and 9
female patients (42.86%) experienced spontaneous abor-
tion. Timely medical consultation and support should
be provided for female recipients who are prepared for
pregnancy. As pregnancy would overload the function of
the kidney grafts, special attention should be paid to
prevent abortion, premature delivery, edema-hypertension-
proteinuria syndrome, infection, and graft function and fetal
abnormality during pregnancy. Based on previous reports
[18,19],the recommended inclusion criteria of pregnancy in
kidney transplant female recipients are as follows: <30 years,
SCr < 176.8µmol/L, no hyperlipemia, no hypertension or
well-controlled hypertension, no proteinuria, good general
conditions, no dilated renal calices as detected by B-
ultrasound, and good tolerance with immunosuppressive
therapy.
In summary, with the development of social civilization,
a new biopsychosocial medical model has been gradually
recognized. Our study showed that serum pituitary-gonadal
hormone levels were gradually restored to the normal range,
and sexual and reproductive functions were also signiﬁ-
cantly improved after kidney transplantation, indicating that
successful kidney transplantation could eﬀectively improve
pituitary-gonadal hormone disturbance and sexual and
reproductive dysfunction in ESRD patients. Nevertheless,
some recipients had a misunderstanding or psychologic
barriers about postoperative sexual activity and fertility,
and some other recipients were unable to get appropriate
health care and psychological support from their spouses.
It is therefore important and necessary to provide kid-
ney graft recipients with timely medical education and
psychological support after successful kidney transplanta-
tion.
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